An FDA advisory panel has recommended making six unapproved peptides more accessible through compounding pharmacies - but scientists warn that easier access does not mean these experimental products have been proven safe or effective.
An FDA advisory panel has recommended making six unapproved peptides more accessible through compounding pharmacies - but scientists warn that easier access does not mean these experimental products have been proven safe or effective.